 - Patient has received chemotherapy, targeted anticancer therapy, pelvic andor para-aortic radiotherapy or has had major surgery 4 weeks 6 weeks for nitrosourea, monoclonal antibodies or mitomycin-C prior to starting study drug or who have not recovered from side effects of such therapy 